Moreover, transgenic animals expressing the GH antagonist G120 GH had lower IGF-1 levels and exhibited decreased tumor incidence in the mammary gland relative to control mice after being treated with the carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) [60]. The gene discussed is GH1; the disease is neoplasm.